Nuzenio

Ligand Pharmaceuticals

Ligand Pharmaceuticals news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 10 publisher sources 100/100 entity strength

Latest news

Timeline

Sat, 08 Aug 2026 19:56:43 GMTA Quick Look at Today's Ratings for Ligand Pharmaceuticals(LGND.US), With a Forecast Between $326 to $370 - Moomoo
Sat, 08 Aug 2026 06:06:18 GMTLGND SWOT Analysis: Strong Revenue Growth Amidst Valuation Concerns Revealed in 10-Q Filing - GuruFocus
Fri, 07 Aug 2026 20:24:12 GMTLGND Maintained by RBC Capital -- Price Target Raised to $345 - GuruFocus
Fri, 07 Aug 2026 12:48:53 GMTLigand Pharmaceuticals, Inc. : H.c. Wainwrigh - Moomoo
Fri, 07 Aug 2026 07:46:55 GMTLigand Pharmaceuticals (LGND) Posts Strong Q2 Results, Is The Upside Already Priced In? - simplywall.st
Fri, 07 Aug 2026 03:46:19 GMTLIGAND PHARMACEUTICALS, INC. : H.C. WAINWRIGHT RAISES TARGET PRICE TO $358 FROM $289 - Bitget

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Ligand Pharmaceuticals.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

10 distinct publisher/source names are currently connected to this entity page.